Human haptoglobin: an endogenous inhibitor of prostaglandin synthase

  • S. A. Saeed
  • P. A. Denning-Kendall
  • W. J. McDonald-Gibson
  • H. O. J. Collier
Part of the Inflammation: Mechanisms and Treatment book series (FTIN, volume 4)


Human blood plasma haptoglobin (Hp) is a well-characterized glycoprotein present in the α2-globulin fraction of most mammalian plasma or serum. The most characteristic property of Hp is to bind haemoglobin (Hb) stoichio-metrically and irreversibly. Several good reviews9,17 have appeared on the chemistry and physiology of Hp. but its exact physiological function still remains uncertain. It is well known that Hp levels in the serum vary greatly in different conditions. It is usually elevated in inflammatory conditions and acute infections, but depressed in severe chronic liver disease and certain haemolytic conditions7. For the past few years we have been studying the inhibition of prostaglandin (PG) biosynthesis by human blood plasma or serum7,14. These studies demonstrated that Hp potently inhibits PG synthesis. This finding suggested that the biological function of Hp may be associated with the inhibition of PG synthesis in vivo. We have therefore evaluated the effects of purified Hp on several test systems used to study PG synthase inhibitors.


Arachidonic Acid Acetyl Salicylate Standard Assay Mixture Dexamethasone Sodium Phosphate Hydrocortisone Sodium Succinate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Collier, H. O. J., Denning-Kendall, P. A., McDonald-Gibson, W.J. and Saeed, S.A. (1980). In Remuzzi, G., Mecca, G. and de Gactano, G (eds) Hemostasis, Prostaglandins and Renal Diseases, pp 257–267. New York: Raven PressGoogle Scholar
  2. 2.
    Collier, H.O. J., McDonald-Gibson, W.J. and Saeed, S. A. (1976). Br. J. Pharmacol, 58, 193PubMedGoogle Scholar
  3. 3.
    Connell G. E. and Smithies, O. (1958). Biochem. J., 72. 115Google Scholar
  4. 4.
    Deby, C., Caneghem Van, P. and Bacq, Z. M. (1978). Biochem. Pharmacol., 27, 613PubMedCrossRefGoogle Scholar
  5. 5.
    Dobryszycka, W. and Lisowska, E. (1966). Biochem. Biophys. Acta, 121, 42PubMedCrossRefGoogle Scholar
  6. 6.
    Eckenfels, A. and Vane, J. R. (1972). Br. J. Pharmacol. 45, 451PubMedGoogle Scholar
  7. 7.
    Higginbotham, T. W. (1975). J. Tenn. Med. Assoc, 68, 116PubMedGoogle Scholar
  8. 8.
    Laurell, C. B. and Nyman, M. (1957). Blood, 12, 493PubMedGoogle Scholar
  9. 9.
    Lee, T. H. and Shim, B. S. (1973). Postgrad. Med. Digest. (Seoul), 1, 2,Google Scholar
  10. 9a.
    Lee, T. H. and Shim, B. S. (1973). Postgrad. Med. Digest. (Seoul), 1, 72,Google Scholar
  11. 9b.
    Lee, T. H. and Shim, B. S. (1973). Postgrad. Med. Digest. (Seoul), 1, 114 andGoogle Scholar
  12. 9c.
    Lee, T. H. and Shim, B. S. (1973). Postgrad. Med. Digest. (Seoul), 1, 141Google Scholar
  13. 10.
    Nyman, M. (1959). Scand. J. Clin. Lab. Invest, 11 (Suppl.), 39Google Scholar
  14. 11.
    Roth, G. J. and Majerus, P. W. (1975). J. Clin. Invest, 56, 624PubMedCrossRefGoogle Scholar
  15. 12.
    Saeed, S. A. and Cuthbert, J. (1977). Prostaglandins, 13, 565PubMedCrossRefGoogle Scholar
  16. 13.
    Saeed, S.A., Kendall, P. A., McDonald-Gibson, W.J. and Collier, H. O.J. (1978). Biochem. Soc. Trans., 6, 1166PubMedGoogle Scholar
  17. 14.
    Saeed, S.A., McDonald-Gibson, W.J., Cuthbert, J., Copas, J.L., Schneider, C., Gardiner, P. J., Butt, N. M. and Collier, H. O. J. (1977). Nature (London), 270, 32CrossRefGoogle Scholar
  18. 15.
    Shim, B. S. (1978). Korean J. Biochem., 10, 23Google Scholar
  19. 16.
    Snellman, O. and Sylven, B. (1967). Nature (London), 216, 1033CrossRefGoogle Scholar
  20. 17.
    Sutton, H. E. (1970). The Haptoglobins. In Steinberg, A. G. and Beam, A. G. (eds) Progr. Med. Geet., 7, pp. 163–216. New York: Grune & StrattonGoogle Scholar
  21. 18.
    Ts’ao, C. and Holly, C. M. (1979). Prostaglandins, 17, 775PubMedCrossRefGoogle Scholar
  22. 19.
    Whittle, B. J. R. (1978). J. Pharm. Pharmacol., 30, 467PubMedCrossRefGoogle Scholar
  23. 20.
    Ubatuba, F. B. (1973). Br. J. Pharmacol., 49, 662PubMedGoogle Scholar

Copyright information

© MTP Press Limited 1980

Authors and Affiliations

  • S. A. Saeed
    • 1
  • P. A. Denning-Kendall
    • 1
  • W. J. McDonald-Gibson
    • 1
  • H. O. J. Collier
    • 1
  1. 1.UK

Personalised recommendations